Perrigo Company plc

Perrigo Company plc

PRGOยทNYSE

$10.46

-2.8%
HealthcareDrug Manufacturers - Specialty & Generic

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

At a Glance

Live Snapshot
Market Cap$1.45B
EPS-10.2900
P/E Ratio-1.35
Earnings Date08/05/2026
3Y-4.0%
5Y+4.0%
10Y-19.0%
3Y+914.0%
5Y+777.0%
10Y-64.0%
3Y-22.0%
5Y-63.0%
10Y-64.0%
Perrigo Company plc

Perrigo Company plc Profit Bridge

PRGO ยท NYSE
Revenue4.25B
Cost of Goods Sold (2.76B)
Gross Profit1.49B
Operating Expenses (1.15B)
Operating Income343.30M
Interest Expense (162.50M)
Other Income/Expense-1.64B
Pretax Income-1.30B
Income Tax (104.40M)
Net Income-1.43B
Net Income
-1.43B

Profitability Analysis

Gross Margin

35.1%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

8.1%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

-33.5%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Perrigo Company plc Income Statement

PRGO โ€ข NYSE

Perrigo Company plc Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
REVENUE
4.3B
4.4B
4.7B
4.5B
4.1B
4.1B
3.9B
4.7B
4.9B
5.3B
4.6B
4.1B
3.5B
3.2B
2.8B
2.3B
2B
1.8B
1.4B
1.4B
GROSS PROFIT
(2.8B)
(2.8B)
(3B)
(3B)
(2.7B)
(2.6B)
(2.4B)
(2.9B)
(3B)
(3.2B)
(2.9B)
(2.6B)
(2.3B)
(2.1B)
(1.8B)
(1.5B)
(1.4B)
(1.3B)
(1B)
(969.1M)
1.5B
1.5B
1.7B
1.5B
1.4B
1.5B
1.4B
1.8B
2B
2.1B
1.7B
1.4B
1.3B
1.1B
944.9M
746M
596M
551M
401.6M
397.7M
OPERATING INCOME
(1.2B)
(1.4B)
(1.5B)
(1.4B)
(1B)
(1.2B)
(1.3B)
(1.3B)
(1.3B)
(1.4B)
(959.6M)
(827.7M)
(589M)
(517.6M)
(411.3M)
(381.6M)
(333.8M)
(348.4M)
(293.9M)
(277.6M)
(526.5M)
(1.1B)
(1.3B)
(1.2B)
(1.1B)
(1.1B)
(1.1B)
(1.1B)
(1.1B)
(1.2B)
(771.8M)
(675.2M)
(473.8M)
(473.8M)
(411.8M)
(299.1M)
(255.8M)
(276.2M)
(227.5M)
(225.3M)
(95.4M)
(112.2M)
(122.5M)
(123.1M)
(122M)
(121.7M)
(119.2M)
(218.6M)
(167.7M)
(184M)
(187.8M)
(152.5M)
(115.2M)
(105.8M)
(89.3M)
(82.5M)
(77.9M)
(72.2M)
(66.5M)
(52.3M)
343.3M
112.9M
151.9M
78.9M
410.4M
265.2M
174.7M
236.5M
598.2M
-2B
747.6M
567M
679.1M
569.2M
490.2M
335.9M
247.3M
197.5M
98.6M
111.3M
PRE-TAX INCOME
(162.5M)
(187.8M)
(173.8M)
(156M)
(125M)
(127.7M)
(126.5M)
(129M)
(173.4M)
(218.8M)
(155.7M)
(175.8M)
(103.5M)
(0.0)
(60.7M)
(28.8M)
(27.2M)
(17M)
(16M)
(5.4M)
-162.5M
-187.8M
-173.8M
-156M
-125M
-127.7M
-126.5M
-129M
-173.4M
-218.8M
-155.7M
-175.8M
-103.5M
0.0
-60.7M
-42.3M
-28.4M
-27.2M
-17.4M
-16M
(529.3M)
(205M)
(131.4M)
(43.3M)
-227.6M
-1.1M
(42.6M)
-6.1M
(10.1M)
(0.0)
(0.0)
(0.0)
-900K
(0.0)
-42.3M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-1.6B
-193.6M
-160.2M
-218M
-151.7M
-259.3M
-26.7M
54.1M
-318.1M
-2.8B
-499.6M
-412.2M
-267.8M
-71.4M
-57.2M
-39.6M
-27.3M
-43.5M
-16.9M
-5.4M
-1.3B
-80.7M
-8.3M
-139.1M
258.7M
5.9M
148M
290.6M
280.1M
-4.8B
248M
272.6M
607.7M
512M
450.6M
308.2M
203.8M
180.4M
89.1M
105.9M
NET INCOME
(104.4M)
(80M)
-3.9M
-8.2M
(389.6M)
-38.3M
-10.7M
(159.6M)
(160.5M)
-835.5M
(120.1M)
(67.3M)
(165.8M)
(119M)
(110M)
(84.1M)
(62.7M)
(44.7M)
(15.3M)
(34.5M)
-1.4B
-171.8M
-12.7M
-140.6M
-68.9M
-162.6M
146.1M
131M
119.6M
-4B
127.9M
205.3M
441.9M
401.6M
339.2M
222.5M
144M
135.8M
73.8M
71.4M

SEC Filings

PRGO - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 06, 2026
May 06, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 06, 2026
March 28, 2026
2026
8-K

8-K 2026

N/A

May 05, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

April 22, 2026
April 22, 2026
2026
8-K

8-K 2026

N/A

March 23, 2026
March 20, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 20, 2026
April 30, 2026
2026
10-K

10-K 2025 FY

FY

February 26, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 05, 2025
September 27, 2025
2025
Showing 1 to 10 of 275 filings